|
CCDC107 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.102400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.324600E-01 |
| Normal-vs-Stage2 |
5.054400E-01 |
| Normal-vs-Stage3 |
2.328200E-01 |
| Normal-vs-Stage4 |
1.099790E-02 |
| Stage1-vs-Stage2 |
1.654160E-01 |
| Stage1-vs-Stage3 |
8.640400E-01 |
| Stage1-vs-Stage4 |
7.526400E-02 |
| Stage2-vs-Stage3 |
1.565980E-01 |
| Stage2-vs-Stage4 |
2.511800E-02 |
| Stage3-vs-Stage4 |
1.727020E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.446810E-01 |
| Normal-vs-AfricanAmerican |
2.831000E-01 |
| Normal-vs-Asian |
9.436400E-02 |
| Caucasian-vs-AfricanAmerican |
7.425800E-01 |
| Caucasian-vs-Asian |
5.263800E-01 |
| AfricanAmerican-vs-Asian |
9.673000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.532200E-01 |
| Normal-vs-Female |
1.023040E-01 |
| Male-vs-Female |
1.079030E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.526650E-01 |
| Normal-vs-Age(41-60Yrs) |
1.650550E-01 |
| Normal-vs-Age(61-80Yrs) |
9.626800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.758400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.610600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.152800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.203200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.433200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.808800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.249000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.215000E-01 |
| Classical-VS-Follicular |
5.82129999999736E-05 |
| Classical-VS-Other |
5.692000E-01 |
| Classical-VS-Normal |
2.749900E-02 |
| Tall-VS-Follicular |
7.378300E-04 |
| Tall-VS-Other |
4.399600E-01 |
| Tall-VS-Normal |
3.456300E-02 |
| Follicular-VS-Other |
6.433800E-01 |
| Follicular-VS-Normal |
3.915800E-02 |
| Other-VS-Normal |
8.628000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.573600E-01 |
| Normal-vs-N1 |
5.113400E-01 |
| N0-vs-N1 |
3.312400E-01 |
|
|
